One of these commonly discussed concerns is roseola. Roseola is a herpes family virus, a group of viruses that cause infections in humans and animals. It commonly affects little children under 2 years ...

GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway and clinical sites confirmed Additional data evaluating GEO-CM04S1 as ...

Preliminary results from the phase 1b/2 Olvi-Vec-SCLC-202 trial show that adding olvimulogene nanivacirepvec (olvi-vec; GL-ONC1), a modified oncolytic vaccinia virus, to platinum-based chemotherapy ...

Olvi-Vec (olvimulogene nanivacirepvec), Genelux’s most advanced product candidate is a proprietary, modified oncolytic vaccinia virus, a stable DNA virus with a large engineering capacity. Genelux is ...

- U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support traditional approval- WESTLAKE VILLAGE, Calif., March ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Immune memory plays a critical role in the ...

Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small cell lung cancer. The company is also developing V2ACT ...

has served a key role in identifying measles cases — since the classic fever and rash symptoms can be confused clinically with other diseases like scarlet fever or roseola. With a blood sample ...

The global laboratory network, which goes by the acronym GMRLN, has served a key role in identifying measles cases — since the classic fever and rash symptoms can be confused clinically with other ...